Search Within

Semanti Mukherjee

  1. "Center for Hematologic Malignancies"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (3)
Groups
  1. Alumni (GSK) (7)
  2. Center for Hematologic Malignancies (7)
  3. Clinical Genetics Service (7)
  4. Department of Medicine (7)
  5. GSK Faculty (7)
  6. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (7)

More Groups

People
  1. Kenneth Offit (5)
  2. Robert Klein (4)
  3. Alison Schram (3)
  4. Outi Kilpivaara (3)
  5. Ross Levine (3)
  6. Vijai Joseph (3)

More People

Years
  1. 2021 (1)
  2. 2017 (1)
  3. 2014 (1)
  4. 2011 (1)
  5. 2010 (1)
  6. 2009 (2)
Publications
  1. Blood (1)
  2. Cancer Research (1)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. Haematologica (1)
  5. JAMA - Journal of the American Medical Association (1)
  6. Nature Cancer (1)

More Publications

Publishers
  1. American Association for Cancer Research (1)
  2. American Medical Association (1)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)
  5. Ferrata Storti Foundation (1)
  6. Nature Publishing Group (1)

More Publishers

Results (7)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
    Journal Article

    Fiala, E. M.; Jayakumaran, G.; Mauguen, A.; Kennedy, J. A.; Bouvier, N.; Kemel, Y.; Fleischut, M. H.; Maio, A.; Salo-Mullen, E. E.; Sheehan, M.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Mutation detection in patients with advanced cancer by universal sequencing of cancer-related genes in tumor and normal DNA vs guideline-based germline testing
    Journal Article

    Mandelker, D.; Zhang, L.; Kemel, Y.; Stadler, Z. K.; Joseph, V.; Zehir, A.; Pradhan, N.; Arnold, A.; Walsh, M. F.; Li, Y.; more...
    JAMA - Journal of the American Medical Association (2017)

    Fulltext@MSK | Save
  • Targeting the cell cycle regulated CDC7 kinase pathway as a novel therapeutic approach for hematologic malignancies
    Meeting Abstract

    Santos, R.; Shum, D.; Churchill, M.; Mukherjee, S.; Brentjens, R. J.; Jurcic, J. G.; Kelly, T.; Djaballah, H.; Frattini, M. G.
    Clinical Lymphoma, Myeloma and Leukemia (2014)

    Fulltext@MSK | Save
  • Genetic and functional investigation of germline JAK2 alleles that predispose to myeloproliferative neoplasms
    Meeting Abstract

    Schram, A. M.; Xu, X.; Kilpivaara, O.; Mukherjee, S.; Viny, A. D.; Guryanova, O.; Klein, R. J.; Levine, R. L.
    Blood (2011)

    Fulltext@MSK | Save
  • Genome-wide association analysis of familial lymphoma
    Meeting Abstract

    Kirchhoff, T.; Joseph, V.; Brown, J.; Dutra Clarke, A.; Gaudet, M. M.; Paltiel, O.; Ben-Yehuda, D.; McGhee, K.; Gold, B.; Devlin, V.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • A germline JAK2 SNP is associated with predisposition to the development of JAK2 V617f-positive myeloproliferative neoplasms
    Meeting Abstract

    Kilpivaara, O.; Mukherjee, S.; Schram, A.; Wadleigh, M.; Mullally, A.; Ebert, R.; Bass, A.; Marubayashi, S.; Heguy, A.; Garcia-Manero, G.; more...
    Haematologica (2009)

    Fulltext@MSK | Save
  • A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms
    Journal Article

    Kilpivaara, O.; Mukherjee, S.; Schram, A. M.; Wadleigh, M.; Mullally, A.; Ebert, B. L.; Bass, A.; Marubayashi, S.; Heguy, A.; Garcia-Manero, G.; more...
    Nature Genetics (2009)

    Fulltext@MSK | Save